Prot #NU 18I01: A Phase 2 study of pembrolizumab in combination with pelareorep in patients with advanced pancreatic adenocarcinoma

Project: Research project

Project Details

StatusActive
Effective start/end date7/5/187/5/24

Funding

  • Oncolytics Biotech Inc. ((OE) Prot #NU 18I01)